T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$2.18B |
| 2 |
Airbnb
ABNB
|
+$1.59B |
| 3 |
Goldman Sachs
GS
|
+$1.35B |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.27B |
| 5 |
Caterpillar
CAT
|
+$1.24B |
Top Sells
| 1 |
Apple
AAPL
|
+$2.44B |
| 2 |
Qualcomm
QCOM
|
+$1.64B |
| 3 |
Becton Dickinson
BDX
|
+$1.61B |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.43B |
| 5 |
Fidelity National Information Services
FIS
|
+$1.04B |
Sector Composition
| 1 | Technology | 25.04% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.91% |
| 4 | Financials | 12.32% |
| 5 | Communication Services | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1176
DELISTED
SpringWorks Therapeutics
SWTX
| $23.7M | ﹤0.01% |
+326,180
| New | +$23.7M |
|
1177
Utah Medical Products
UTMD
$200M
| $23.6M | ﹤0.01% |
280,128
-19
| -0% | -$1.6K |
|
1178
Innovative Industrial Properties
IIPR
$1.6B
| $23.6M | ﹤0.01% |
128,851
+118,536
| +1,149% | +$21.7M |
|
1179
National CineMedia
NCMI
$455M
| $23.6M | ﹤0.01% |
633,486
-2,020
| -0.3% | -$75.1K |
|
1180
Baker Hughes
BKR
$45.8B
| $23.5M | ﹤0.01% |
1,126,946
-63,330
| -5% | -$1.32M |
|
1181
Athira Pharma
ATHA
$14.2M
| $23.3M | ﹤0.01% |
681,560
-200,440
| -23% | -$6.86M |
|
1182
Eastman Chemical
EMN
$7.71B
| $23.3M | ﹤0.01% |
232,320
-10,759
| -4% | -$1.08M |
|
1183
Cincinnati Financial
CINF
$24.5B
| $23.2M | ﹤0.01% |
265,886
-13,128
| -5% | -$1.15M |
|
1184
J.M. Smucker
SJM
$11.5B
| $23.2M | ﹤0.01% |
200,489
-9,939
| -5% | -$1.15M |
|
|
AXNX
1185
DELISTED
Axonics, Inc. Common Stock
AXNX
| $23.1M | ﹤0.01% |
462,732
-312
| -0.1% | -$15.6K |
|
1186
Blackstone
BX
$142B
| $23.1M | ﹤0.01% |
355,754
-6,380
| -2% | -$413K |
|
1187
Hormel Foods
HRL
$13.8B
| $23M | ﹤0.01% |
494,131
-14,096
| -3% | -$657K |
|
1188
NCR Voyix
VYX
$1.77B
| $22.9M | ﹤0.01% |
995,612
+119,278
| +14% | +$2.75M |
|
1189
Boston Properties
BXP
$12.2B
| $22.9M | ﹤0.01% |
242,144
-313,863
| -56% | -$29.7M |
|
1190
TherapeuticsMD
TXMD
$12.8M
| $22.8M | ﹤0.01% |
377,384
-3,772
| -1% | -$228K |
|
|
DMYD
1191
DELISTED
dMY Technology Group, Inc. II
DMYD
| $22.8M | ﹤0.01% |
+1,297,638
| New | +$22.8M |
|
1192
John B. Sanfilippo & Son
JBSS
$737M
| $22.7M | ﹤0.01% |
288,283
-3,830
| -1% | -$302K |
|
|
ELME
1193
Elme Communities
ELME
$1.51B
| $22.7M | ﹤0.01% |
1,048,072
-727,236
| -41% | -$15.7M |
|
1194
Blackstone Mortgage Trust
BXMT
$3.35B
| $22.6M | ﹤0.01% |
821,090
+1,643
| +0.2% | +$45.2K |
|
1195
Karyopharm Therapeutics
KPTI
$55.9M
| $22.6M | ﹤0.01% |
97,127
+1,326
| +1% | +$308K |
|
1196
Q32 Bio
QTTB
$23.5M
| $22.4M | ﹤0.01% |
110,350
-26,824
| -20% | -$5.45M |
|
1197
LPL Financial
LPLA
$28.1B
| $22.3M | ﹤0.01% |
213,937
-632,455
| -75% | -$65.9M |
|
1198
ON Semiconductor
ON
$19.7B
| $22.2M | ﹤0.01% |
679,618
+279,513
| +70% | +$9.15M |
|
1199
Evergy
EVRG
$16.7B
| $22.1M | ﹤0.01% |
398,129
-20,913
| -5% | -$1.16M |
|
1200
Pacira BioSciences
PCRX
$1.22B
| $22.1M | ﹤0.01% |
369,289
-2,932
| -0.8% | -$175K |
|